Mild cognitive impairment (MCI)

Oct. 24, 2024

Mild cognitive impairment care at Mayo Clinic

Your Mayo Clinic care team

Mayo Clinic neurologists, mental health specialists (psychiatrists and psychologists), imaging specialists (radiologists), sleep medicine specialists and others work together to diagnose and treat people with mild cognitive impairment.

Mayo Clinic experts work together as a team to determine the most appropriate treatment for you. Your care is discussed among the team, your test results are available quickly, appointments are scheduled in coordination and the most highly specialized experts in the world are all working together to determine what's best for you.

What might take months to accomplish elsewhere can typically be done in a matter of only days at Mayo Clinic.

Individualized treatment

Your healthcare professional works with you to develop a treatment plan appropriate for you and your family's needs.

Research

Mayo Clinic doctors conduct extensive research on mild cognitive impairment, Alzheimer's disease and other dementias, and conduct clinical trials. You may have an opportunity to participate in a clinical trial as part of your treatment at Mayo Clinic.

Family support and education

Your Mayo Clinic care team will work with you and your family to help you learn more about mild cognitive impairment and the steps you can take to manage your condition.

Expertise and rankings

Experience

Every year, Mayo Clinic doctors trained in brain and nervous system conditions (neurologists) evaluate and treat more than 4,300 people with mild cognitive impairment and other neurological conditions.

Advanced research and treatment

Mayo Clinic researchers actively study mild cognitive impairment, Alzheimer's disease and other conditions that affect your memory and thinking skills.

Nationally recognized expertise

  1. Knopman DS, et al. Alzheimer disease. Nature Reviews. Disease Primers. 2021; doi:10.1038/s41572-021-00269-y.
  2. Jankovic J, et al., eds. Alzheimer disease and other dementias. In: Bradley and Daroff's Neurology in Clinical Practice. 8th ed. Elsevier; 2022. https://www.clinicalkey.com. Accessed Sept. 21, 2022.
  3. Zhuang L, et al. Cognitive assessment tools for mild cognitive impairment screening. Journal of Neurology. 2021; doi:10.1007/s00415-019-09506-7.
  4. What is mild cognitive impairment? National Institute on Aging. https://www.nia.nih.gov/health/what-mild-cognitive-impairment. Accessed Aug. 29, 2024.
  5. Mild cognitive impairment (MCI). Alzheimer's Association. https://www.alz.org/alzheimers-dementia/what-is-dementia/related_conditions/mild-cognitive-impairment. Accessed Aug. 29, 2024.
  6. Lewis JE, et al. The effects of twenty-one nutrients and phytonutrients on cognitive function: A narrative review. Journal of Clinical and Translational Research. 2021; doi:10.18053/jctres.07.202104.014.
  7. Kellerman RD, et al. Alzheimer's disease. In: Conn's Current Therapy 2022. Elsevier; 2022. https://www.clinicalkey.com. Accessed Aug. 29, 2024.
  8. Ferri FF. Mild cognitive impairment. In: Ferri's Clinical Advisor 2023. Elsevier; 2023. https://www.clinicalkey.com. Accessed Aug. 29, 2024.
  9. Petersen RC, et al. Practice guideline update summary: Mild cognitive impairment: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology. Neurology. 2018; doi:10.1212/WNL.0000000000004826.
  10. Budson AE, et al. Memory Loss, Alzheimer's Disease, and Dementia. 3rd ed. Elsevier; 2022. https://www.clinicalkey.com. Accessed Aug. 29, 2024.
  11. Cognitive impairment in older adults: Screening. U.S. Preventive Services Task Force recommendation statement. https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/cognitive-impairment-in-older-adults-screening. Accessed Aug. 29, 2024.
  12. Petersen RC. Mild cognitive impairment: Epidemiology, pathology, and clinical assessment. https://www.uptodate.com/contents/search. Accessed Aug. 29, 2024.
  13. Livingston G, et al. Dementia prevention, intervention, and care: 2024 report of the Lancet Standing Commission. The Lancet. 2024; doi:10.1016/S0140-6736(24)01296-0.
  14. Cummings J, et al. Alzheimer's disease drug development pipeline: 2022. Alzheimer's and Dementia. 2022; doi:10.1002/trc2.12295.
  15. Memory, forgetfulness and aging: What's normal and what's not? National Institute on Aging. https://www.nia.nih.gov/health/memory-forgetfulness-and-aging-whats-normal-and-whats-not. Accessed Aug. 29, 2024.
  16. Jack CR Jr., et al. Revised criteria for diagnosis and staging of Alzheimer's disease: Alzheimer's Association Workgroup. Alzheimer's & Dementia. 2024; doi:10.1002/alz.13859.
  17. Alzheimer's disease research centers. National Institute on Aging. https://www.nia.nih.gov/health/alzheimers-disease-research-centers#minnesota. Accessed Aug. 23, 2024.
  18. About the Alzheimer's Consortium. Arizona Alzheimer's Consortium. https://azalz.org/about/#institutes. Accessed Aug. 23, 2024.
  19. Shi M, et al. Impact of anti-amyloid-β monoclonal antibodies on the pathology and clinical profile of Alzheimer's disease: A focus on aducanumab and lecanemab. Frontiers in Aging and Neuroscience. 2022; doi:10.3389/fnagi.2022.870517.
  20. Nimmagadda R. Allscripts EPSi. Mayo Clinic. Sept. 23, 2024.
  21. 2024 Alzheimer's disease facts and figures. Alzheimer's Association. https://www.alz.org/alzheimers-dementia/facts-figures. Accessed Aug. 26, 2024.
  22. Halter JB, et al., eds. Cognitive changes in normal and pathologic aging. In: Hazzard's Geriatric Medicine and Gerontology. 8th ed. McGraw Hill; 2022. https://accessmedicine.mhmedical.com. Accessed Sept. 17, 2024.
  23. Proton pump inhibitors. Facts & Comparisons eAnswers. https://fco.factsandcomparisons.com. Accessed Sept. 8, 2024.
  24. Kang C. Donanemab: First approval. Drugs. 2024; doi:10.1007/s40265-024-02087-4.
  25. Donanemab injection. Facts & Comparisons eAnswers. https://fco.factsandcomparisons.com. Accessed Sept. 6, 2024.
  26. Lecanemab injection. Facts & Comparisons eAnswers. https://fco.factsandcomparisons.com. Accessed Sept. 6, 2024.